InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Barrett Elizabeth A., Chief Executive Officer. Director active across 2 companies, notably UroGen Pharma Ltd.. Cumulatively, 7 reports have been logged. Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Barrett Elizabeth A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,000 sharesCommon StockSEC:0000950170-25-100675:0
5,000 sharesOrdinary SharesSEC:0001437749-23-002358:0
5,000 sharesOrdinary SharesSEC:0001209191-22-006383:0
105,689 sharesOrdinary SharesSEC:0001209191-22-002305:0
8,807 sharesOrdinary SharesSEC:0001209191-21-046340:0
8,807 sharesOrdinary SharesSEC:0001209191-21-046344:0
8,807 sharesOrdinary SharesSEC:0001209191-21-034823:0
7 of 7 declarations
About Barrett Elizabeth A.
Barrett Elizabeth A. is the Chief Executive Officer of UroGen Pharma Ltd. She leads the company with a strategic vision focused on innovation and the development of treatments for urological diseases. Elizabeth plays a crucial role in defining the company's objectives and overseeing its operations to ensure growth and success.
